Records containing: Neuroendocrine Tumors
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-04-12An Expanded Access Program of Surufatinib for Patients With Advanced or Metastatic Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2024-03-26Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2024-03-20Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications
-
CLINICAL_TRIALS study record update · 2024-03-13Phase I, Open-Label Study of the Safety and Dosimetry of a 3-Dose Regimen of Escalating Doses of 177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2024-03-12Financial Toxicity and Patient-Reported Outcomes in Italian Patients Affected by Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-03-08A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2024-03-06Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.
-
CLINICAL_TRIALS study record update · 2024-02-29Treatment Preferences for Somatuline® Injector Devices: A Discrete Choice Experiment (DCE) of Patients With Neuroendocrine Tumors (NETs) and Nurses in the United States (US) and Canada
-
CLINICAL_TRIALS study record update · 2024-02-21Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma: Clinical and Morphological Findings, and Therapeutic Options (IPANEMA)
-
CLINICAL_TRIALS study record update · 2024-02-13Safety and Efficacy of Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment of Functional and Non-functional Pancreatic NeuroEndocrine Neoplasms: A Multicenter Prospective Study
-
CLINICAL_TRIALS study record update · 2024-01-18Clinical Application of the Prototype J-PET Device
-
CLINICAL_TRIALS study record update · 2024-01-17The Clinical Impact of 68Ga-DOTATATE PET in the Management of Patients With Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2024-01-09An Open-Label, Single Arm Phase II Study of Nivolumab in Combination With Ipilimumab in Subjects With Advanced Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2023-12-26Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors
-
CLINICAL_TRIALS study record update · 2023-12-05Phase I/IIa Study to Evaluate the Safety, Tolerability, Whole-body Distribution, and Preliminary Diagnostic Performance of a Novel 68Ga-labelled Minigastrin Analogue in Patients With Advanced Neuroendocrine Tumours
-
CLINICAL_TRIALS study record update · 2023-11-28Clinical and Pathologic Studies in Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2023-11-28Selective Intra-arterial Injection of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumor Patients With Liver Metastases
-
CLINICAL_TRIALS study record update · 2023-11-22Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors Based on the Pathological Evaluation Following Initial Endoscopic Resection: A Multi-center Study
-
CLINICAL_TRIALS study record update · 2023-11-22Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
-
CLINICAL_TRIALS study record update · 2023-09-29Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms - a Feasibility Study
-
CLINICAL_TRIALS study record update · 2023-09-18A Prospective Study to Evaluate the Lesion Detection Ability of Gallium-68 NODAGA-JR11 for the Diagnostic Imaging of Metastatic, Well-differentiated Neuroendocrine Tumors Using PET/CT
-
CLINICAL_TRIALS study record update · 2023-08-29Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2023-08-07A Phase II, Open-Label, Single Arm Decentralized Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-08-01Investigating the Clinical Trial Journey and Engagement of Neuroendocrine Tumor Patients
-
CLINICAL_TRIALS study record update · 2023-07-27A Phase II Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres (SIR-Spheres®)